Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Ascentage Pharma Announces Clearances for Three Phase Ib/II Clinical Studies of APG-2575 in China and the U.S., Beginning Simultaneous Clinical Development in Three Hematologic Malignancy Indications 2020-03-09 20:00
NAGASE/Nagase Medicals and Osaka University Launch Joint Research Program 2020-03-05 14:00
Zuellig Pharma acquires Alliance Pharma (Cambodge) in Cambodia to strengthen Indochina presence 2020-03-05 08:15
NDA Filing for Luye Pharma's Antidepressant Drug LY03005 Accepted by the U.S. FDA 2020-03-04 21:27
New Disinfection Spray From Lipidor and Aurena Laboratories 2020-03-04 15:20
DoctorOnCall Partners Merchantrade Money to Offer Convenient Digital Health Service to App Users 2020-03-04 13:30
Merck's New LANEXO™ System to Improve Scientists' Productivity in the Lab 2020-03-04 03:00
China Biologic Products to Report Fourth Quarter and Fiscal Year 2019 Financial Results 2020-03-03 21:30
Inovio Accelerates Timeline for COVID-19 DNA Vaccine INO-4800 2020-03-03 21:00
CROMSOURCE Announces a Significant Milestone in Digital Management of Its Projects in Cooperation with Techorizon 2020-03-03 20:00
Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug 2020-03-03 03:00
Bactiguard Completes Acquisition of Vigilenz 2020-03-02 22:06
Yuyu Pharma announces review of compliance policies and procedures 2020-03-02 22:00
China Pharmaceutical Holdings Co., Ltd. Launched A New Product 2020-03-02 20:00
ConvaTec sharpens focus on Asia Pacific and emerging markets 2020-03-02 18:06
Yuyu Pharma, Laying the foundation for establishing a global-level compliance system with one of Korea's top law firms 2020-03-02 17:00
ERBITUX® Approved for First-line Use in China in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) 2020-03-02 15:02
Sihuan Pharmaceutical Announces Clinical Research of Favipiravir, Co-Developed with the Academy of Military Medical Sciences of the People's Liberation Army, Has Commenced 2020-03-02 14:15
Luminex Corporation Submits VERIGENE(R) II Respiratory Flex Assay for FDA Clearance 2020-03-02 10:00
Tessa Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to its CD30 CAR-T Cell Therapy for the Treatment of Relapsed or Refractory CD30-positive Classical Hodgkin Lymphoma 2020-02-27 20:00
1 303 304 305 306 307 412